 |
|
 |
|
Medtronic® Resting Heart® System offers a New Approach to Reducing Cardiac Surgery Morbidity

TEAMWORK

TECHNIQUE

TECHNOLOGY
|
- Using closed-to-air systems to eliminate an air-blood interface that can activate blood.1,2,3
- Minimizing hemodilution and circuit surface area by using low-prime circuits, retrograde autologous priming (or RAP) techniques, and strategies for fluid management43,44,45,46 to reduce bleeding with higher postoperative hematocrits.
- Coating blood-contacting surfaces with Carmeda®* BioActive Surface (a heparin bioactive surface) which mimics critical characteristics of vascular endothelium to provide thromboresistance and biocompatibility.
24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40
- Sequestering shed and suctioned blood to prevent the development of systemic inflammatory response and keep air, lipids and particulate emboli from being introduced into the patient’s circulation.1,2,3,4
- Optimizing anticoagulation using a hemostasis management system that identifies patient specific heparin and protamine requirements.1,2,3,42
- Realize potential savings from a reduction in blood product usage.56
|
* Carmeda® BioActive Surface. Manufactured under license from Carmeda
AB, Sweden. Carmeda is a registered trademark of Carmeda AB.
|
|